Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

RELUGOLIX

FDA · NDA · 2025-10-08

AgencyFDA
Submission typeNDA
Action date2025-10-08
BrandORGOVYX
SponsorSUMITOMO PHARMA AM
RouteORAL

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:34:01.207Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:RELUGOLIX:2025-10-08

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

RELUGOLIX — approval | AEaH